Reaction

Neck Surgery reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,267 reports · 57 co-occurring drugs

As of the last recalculation, Neck Surgery appears in 2,267 FAERS reports alongside 57 co-occurring drug terms. The strongest observed disproportionality signal is UPADACITINIB (PRR 20.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Upadacitinib	171	20.7	20.8
Calcium, Magnesium, Potassium, And Sodium Oxybates	19	20.4	20.5
Risankizumab-Rzaa	128	15.2	15.2
Methocarbamol Tablets	23	12.7	12.7
Sodium Oxybate	75	10.8	10.8
Oxymorphone Hydrochloride	13	10.3	10.3
Methocarbamol	23	9.4	9.4
Armodafinil	20	8.8	8.8
Tizanidine Hydrochloride	16	8.2	8.2
Carisoprodol	15	7.3	7.3
Buspirone Hydrochloride	8	6.7	6.7
Modafinil	23	6.6	6.6
Tizanidine	17	6.6	6.6
Meloxicam	39	6.3	6.3
Ranolazine	7	6.2	6.2
Bosutinib	6	6.1	6.1
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	23	6.0	6.0
Pancrelipase	24	5.8	5.8
Bimekizumab	12	5.2	5.2
Testosterone Cypionate	5	5.1	5.2
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	23	5.1	5.1
Hydrocodone Bitartrate And Acetaminophen	31	5.1	5.1
Carboxymethylcellulose Sodium	5	4.9	4.9
Fluticasone Furoate And Vilanterol Trifenatate	19	4.9	4.9
Tofacitinib	93	4.8	4.8
Tafamidis	6	4.7	4.7
Esketamine Hydrochloride	9	4.6	4.7
Belimumab	15	4.4	4.4
Oxycodone And Acetaminophen	11	4.3	4.4
Linaclotide	11	3.8	3.8
Avapritinib	5	3.8	3.8
Oxycodone Hydrochloride	87	3.8	3.8
Fluticasone Propionate And Salmeterol	17	3.8	3.8
Rimegepant Sulfate	5	3.6	3.6
Guselkumab	14	3.6	3.6
Abatacept	49	3.3	3.3
Etanercept	200	3.3	3.3
Teriflunomide	16	3.3	3.3
Sarilumab	9	3.1	3.1
Cenegermin-Bkbj	4	3.0	3.0
Alirocumab	8	2.9	2.9
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	13	2.9	2.9
Onabotulinumtoxina	24	2.9	2.9
Ixekizumab	11	2.7	2.7
Ethyl Alcohol	8	2.7	2.7
Dimethyl Fumarate	33	2.5	2.5
Emtricitabine And Tenofovir Alafenamide	3	2.4	2.4
Fremanezumab-Vfrm	3	2.4	2.4
Abaloparatide	7	2.2	2.2
Velpatasvir And Sofosbuvir	3	2.1	2.1
Patiromer	3	2.0	2.0
Dupilumab	92	1.8	1.8
Relugolix	4	1.6	1.6
Cinacalcet Hydrochloride	7	1.4	1.4
Droxidopa	3	1.3	1.3
Evolocumab	21	1.2	1.2
Pimavanserin Tartrate	7	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.